Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:Dan_Moore
|
| gptkbp:defunct |
2015
|
| gptkbp:focusesOn |
treatment-resistant depression
epilepsy treatment neuromodulation |
| gptkbp:founded |
1987
|
| gptkbp:headquartersLocation |
gptkb:Houston,_Texas,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cyberonics
|
| gptkbp:industry |
medical devices
|
| gptkbp:mergedInto |
gptkb:Sorin_Group
|
| gptkbp:notableProduct |
Vagus Nerve Stimulation (VNS) Therapy System
|
| gptkbp:status |
defunct
|
| gptkbp:stockSymbol |
gptkb:CYBX
|
| gptkbp:successor |
gptkb:LivaNova
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
www.cyberonics.com
|
| gptkbp:bfsParent |
gptkb:vagal_nerve_stimulation
|
| gptkbp:bfsLayer |
7
|